Spectral Medical Inc T.EDT

x sites, y patients, always underwhelming

[Stocktree]

They announced they would have 25 sites up and running in september.
The are still at 19. They never achieve what they promised.
So how can a pumpcycle like MM predict 90 patients in short order, without being pummeled for his ridiculous pumping? Easy, there are about 12 active posters here, some being the same person.

Also, the halfway mark is just that. No reason at all to point at it other than for pumping reasons, or to earn your posting reward.

The number of patients enrolled is a farce, and defies logic.

2 patients a month? That means 17 sites enrolled 0 patients?

Either the study's parameters are so strict any trial success rate will have to be divided by a thousand, or sites only painfully agree to do one single test drive to get Spectral of their back, after which they ghost the company and proceed with their usual business and other trials.

[JohnnyCashMoney]

I have way to much in this because I am still puckering from BIOMS and at this point I can't get out and why bother. I am concerned that if it is this hard to find candidates will there even be a market if approved?

[ChesterLives]

I don't think anybody, in the company or shareholder, is pleased with the pace of enrolment. How could anybody be. Having said that, to suggest there is only a very small market for PMX is to suggest that you know more than Baxter about market size/potential. I think I'll defer to Baxter on that one.

[JohnnyCashMoney]

Thanks... for ... that? 

[JohnnyCashMoney]

You just added nothing? Thanks though

[MMABStrader]

The higher the "better than expectations result" during the test, the bigger the market/acceptance for the treatment once FDA approval is received. Also, if the FDA doesn't stop the test at the mid point of 90 test participants, if the results of the test shows siginificant proof of exceeding expextations, then it's my belief that there is a good chance the FDA stop the test

[mercedesman]

Totally agree.  Stoppage possibility once results are published.  (small correction - this is not at midpoint but 90 of 150 (=60%). Or if you include Euphrates patients that met the Tigris criteria ( which is called for) more like > 80% complete.  But you are also correct that the "confirmation" in this "open" Trial  could become compelling at 100,

[oilandgasman]

Going the full 150, don't be shilled

[mercedesman]

You're the one espousing the "party" line, not I. So I think you are the shill ( how ironic is that)  I'm just stating what could/ should happen ( in order to save thousands of lives)  In any case, I'm sure that Baxter has some good statisticians on board... so the 90/150 debate might be a red herring   MM